Orvil Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Howrah, West Bengal, India, established in 2017.

2017 Howrah, West Bengal, India Active

Last Updated: December 23, 2025

About Orvil Pharmaceuticals Private Limited

Orvil Pharmaceuticals Private Limited, a active private limited company, was established on 18 May 2017 in Howrah, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999WB2017PTC221025. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Soumen Prabhat Sarkar (Director), Nilima Sarkar Soumen (Additional Director). Past directors included Aniruddha Bhowmick. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bl-Vii;3Rd Floor;Fl-3J 321/A G.T Road (Belur) Lp-1/69 Howrah 711202, Howrah, West Bengal, 711202.

Company Details

CIN/LLPIN
U74999WB2017PTC221025
Registration Number
221025
Incorporation Date
18 May 2017
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Kolkata
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 23-12-2025
Paid Up Capital ₹ 0.10 M as on 23-12-2025
Company Age 8 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth **** 84.13% (FY 2020)
Profit Growth **** 9.39% (FY 2020)
Ebitda **** -0.17% (FY 2020)
Net Worth 49.61% (FY 2020)
Total Assets **** 14.45% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Orvil Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Orvil Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Soumen Prabhat Sarkar	Director	18 May 2017	Current
Nilima Sarkar Soumen	Additional Director	02 Jan 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	10 Jan 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orvil Pharmaceuticals.

Orvil Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 84.13% increase. The company also saw a slight improvement in profitability, with a 9.39% increase in profit. The company's net worth Soared by an impressive increase of 49.61%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

84.13%

*******

Revenue from Operations

*******

83.94%

*******

Total Assets

*******

14.45%

*******

Profit or Loss

*******

9.39%

*******

Net Worth

*******

49.61%

*******

EBITDA

*******

-0.17%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orvil Pharmaceuticals?

Unlock access to Orvil Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Orvil Pharmaceuticals?

Unlock and access historical data on people associated with Orvil Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Orvil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orvil Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orvil Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Orvil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

Progress on Orvil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
31 Mar 2024
Director Appointment

Progress on Nilima Sarkar Soumen was appointed as a Additional Director was appointed as a Additional Director on 02 Jan 2018 & has been associated with this company since 8 years 1 month . was documented.
02 Jan 2018
Director Appointment

The activity Soumen Prabhat Sarkar was appointed as a Director was appointed as a Director on 18 May 2017 & has been associated with this company since 8 years 9 months . was completed.
18 May 2017
Company Incorporation

Progress on Orvil Pharmaceuticals Private Limited was registered on 18 May 2017 with Roc Kolkata & aged 8 years 9 months as per MCA records. was documented.
18 May 2017

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Orvil Pharmaceuticals Private Limited?

The CIN of Orvil Pharmaceuticals Private Limited is U74999WB2017PTC221025.

Where is Orvil Pharmaceuticals Private Limited headquartered?

Orvil Pharmaceuticals Private Limited is headquartered at Bl-Vii;3Rd Floor;Fl-3J 321/A G.T Road (Belur) Lp-1/69 Howrah 711202, Howrah, West Bengal, 711202.

When was Orvil Pharmaceuticals Private Limited incorporated?

Orvil Pharmaceuticals Private Limited was incorporated on 18 May 2017.

Who are the current directors of Orvil Pharmaceuticals Private Limited?

The current directors of Orvil Pharmaceuticals Private Limited are

What is the primary industry of Orvil Pharmaceuticals Private Limited?

The primary industry of Orvil Pharmaceuticals Private Limited is Pharma.

Is Orvil Pharmaceuticals Private Limited a listed company?

Orvil Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Orvil Pharmaceuticals Private Limited?

The authorized capital of Orvil Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Orvil Pharmaceuticals Private Limited?

The compliance status of Orvil Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available